PhiChem(SZ:300398)2025-05-15 10:06Group 1: Market Value Management - The company emphasizes strict compliance with laws and regulations regarding market value management to maximize shareholder interests and align market value with intrinsic value [1][2] - In December 2024, the company established a Market Value Management System to enhance management practices and protect investor rights [2] Group 2: Mergers and Acquisitions - The company signed a share transfer agreement to sell 100% of DaRui Technology for RMB 227.5 million, aimed at optimizing financial and asset structures [3] - A memorandum of understanding was signed with JNC Corporation to acquire 100% equity and related patents of two subsidiaries, enhancing market position in the LCD display industry [4] Group 3: Cash Dividends - The company has distributed cash dividends 10 times since its listing, totaling RMB 370 million, with a proposed dividend of RMB 0.65 per share for 2024 [5] Group 4: Investor Relations Management - The company actively engages with investors through various channels, including roadshows and online meetings, responding to 143 investor inquiries on the interactive platform [6] - Five investor relations activity records were disclosed from 2024 to Q1 2025 [6] Group 5: Crisis and Reputation Management - The company maintained a positive market image with no significant negative publicity or crisis events reported in 2024 and Q1 2025 [7] Group 6: Information Disclosure - The company adheres to legal and regulatory requirements for timely and fair disclosure of important information, ensuring clarity and accuracy [8] Group 7: Research and Development - In 2024, the company invested RMB 18.16 million in R&D, accounting for 6.23% of revenue, and holds 734 patents, including 708 invention patents [9][10] - The company developed a new generation of photoinitiators, TMO, to replace TPO, addressing industry challenges and supporting advanced packaging solutions [10]